Recruiting Crohns Disease Studies in Fairfax
A Long-term Extension Study of Ustekinumab in Pediatric Participants
The purpose of this study is to collect long-term safety data of subcutaneous (SC) ustekinumab...
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
The main purpose of this study is to evaluate the long-term efficacy of mirikizumab in pediatric participants with ulcerative colitis (UC) or Crohn's disease (CD). The study will last about 172 weeks ...
About Crohns Disease Clinical Trials in Fairfax
Crohn's disease is a chronic inflammatory bowel disease that causes inflammation anywhere in the digestive tract, most commonly in the small intestine and colon. Symptoms include abdominal pain, diarrhea, fatigue, and weight loss. Treatment includes anti-inflammatory drugs, immunosuppressants, biologics, and surgery.
There are currently 2 crohns disease clinical trials recruiting participants in Fairfax, VA. These studies are seeking a combined 301 participants. Research is being sponsored by Janssen Research & Development, LLC, Eli Lilly and Company. Clinical trial participation is free and participants receive study-related medical care at no cost.
Crohns Disease Clinical Trials in Fairfax — FAQ
Are there crohns disease clinical trials in Fairfax?
Yes, there are 2 crohns disease clinical trials currently recruiting in Fairfax, VA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Fairfax?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fairfax research site will contact you about next steps.
Are clinical trials in Fairfax free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fairfax studies also compensate for your time and travel.
What crohns disease treatments are being tested?
The 2 active trials in Fairfax are testing new therapies including novel drugs, biologics, and treatment approaches for crohns disease.
Data updated March 2, 2026 from ClinicalTrials.gov